SLG-96484-82945
4 vaccinations
1 coded response
15 check-ins
0 free-text entries
0 call cases
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 038 / NH
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Moderna
-
2021-01-21
Dose 2 — Moderna
- 2021-01-21
-
2021-01-21
Health check-in — day 0, dose 2Feeling: Fair · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-07-24
-
2021-12-03
Dose 3 — Moderna
- 2022-01-21
- 2022-03-04
- 2022-06-03
-
2022-09-28
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-07
- 2022-10-12
- 2022-10-21
- 2022-10-26
- 2022-11-04
- 2022-11-09
- 2022-12-28
-
2023-03-29
Survey response — 6 months, dose 4MedDRA: Norovirus infection, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-21 | Moderna | |
| 3 | 2021-12-03 | Moderna | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Norovirus infection | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release